156 related articles for article (PubMed ID: 28782861)
21. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
22. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53.
Mrakovcic M; Bohner L; Hanisch M; Fröhlich LF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544838
[TBL] [Abstract][Full Text] [Related]
24. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.
Brochier C; Dennis G; Rivieccio MA; McLaughlin K; Coppola G; Ratan RR; Langley B
J Neurosci; 2013 May; 33(20):8621-32. PubMed ID: 23678107
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8.
Yan W; Liu S; Xu E; Zhang J; Zhang Y; Chen X; Chen X
Oncogene; 2013 Jan; 32(5):599-609. PubMed ID: 22391568
[TBL] [Abstract][Full Text] [Related]
26. p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death.
Mrakovcic M; Kleinheinz J; Fröhlich LF
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096697
[TBL] [Abstract][Full Text] [Related]
27. HDAC11: a rising star in epigenetics.
Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
[TBL] [Abstract][Full Text] [Related]
28. HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications.
Huang R; Sui L; Fu C; Zhai Y; Dai X; Zhang S; Li Z
Aging (Albany NY); 2021 Mar; 13(6):8849-8864. PubMed ID: 33742608
[TBL] [Abstract][Full Text] [Related]
29. Proliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts.
Bagui TK; Sharma SS; Ma L; Pledger WJ
Cell Cycle; 2013 Nov; 12(21):3433-41. PubMed ID: 24047695
[TBL] [Abstract][Full Text] [Related]
30. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
31. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
[TBL] [Abstract][Full Text] [Related]
32. Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury.
Kim JI; Jung KJ; Jang HS; Park KM
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F61-70. PubMed ID: 23657855
[TBL] [Abstract][Full Text] [Related]
33. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
35. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization.
Kim JH; Moon SH; No M; Kim JJ; Choi EJ; Cho BJ; Kim JS; Kim IH; Kim IA
Cancer Res Treat; 2016 Jul; 48(3):1130-40. PubMed ID: 26582395
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
Knutson AK; Welsh J; Taylor T; Roy S; Wang WL; Tenniswood M
Oncol Rep; 2012 Mar; 27(3):849-53. PubMed ID: 22159450
[TBL] [Abstract][Full Text] [Related]
37. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
38. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
40. Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells.
Venkatesh R; Ramaiah MJ; Gaikwad HK; Janardhan S; Bantu R; Nagarapu L; Sastry GN; Ganesh AR; Bhadra M
Eur J Med Chem; 2015 Apr; 94():87-101. PubMed ID: 25757092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
